Shi, Y.; Zhang, H.; Chen, H.; Guo, J.; Yuan, R.; Tian, Y.; Xin, Q.; Mu, Z.; Tao, Y.; Chu, Y.;
et al. Cetuximab-Immunoliposomes Loaded with TGF-β1 siRNA for the Targeting Therapy of NSCLC: Design, and In Vitro and In Vivo Evaluation. Int. J. Mol. Sci. 2025, 26, 1196.
https://doi.org/10.3390/ijms26031196
AMA Style
Shi Y, Zhang H, Chen H, Guo J, Yuan R, Tian Y, Xin Q, Mu Z, Tao Y, Chu Y,
et al. Cetuximab-Immunoliposomes Loaded with TGF-β1 siRNA for the Targeting Therapy of NSCLC: Design, and In Vitro and In Vivo Evaluation. International Journal of Molecular Sciences. 2025; 26(3):1196.
https://doi.org/10.3390/ijms26031196
Chicago/Turabian Style
Shi, Yanan, Houqian Zhang, Hao Chen, Jianwei Guo, Ranran Yuan, Yu Tian, Quanlin Xin, Zhen Mu, Yuping Tao, Yongchao Chu,
and et al. 2025. "Cetuximab-Immunoliposomes Loaded with TGF-β1 siRNA for the Targeting Therapy of NSCLC: Design, and In Vitro and In Vivo Evaluation" International Journal of Molecular Sciences 26, no. 3: 1196.
https://doi.org/10.3390/ijms26031196
APA Style
Shi, Y., Zhang, H., Chen, H., Guo, J., Yuan, R., Tian, Y., Xin, Q., Mu, Z., Tao, Y., Chu, Y., Wang, A., Zhang, Z., Tian, J., & Wang, H.
(2025). Cetuximab-Immunoliposomes Loaded with TGF-β1 siRNA for the Targeting Therapy of NSCLC: Design, and In Vitro and In Vivo Evaluation. International Journal of Molecular Sciences, 26(3), 1196.
https://doi.org/10.3390/ijms26031196
